当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2013年第17期
编号:13160199
阿尔茨海默病患者尿液生物标志物的检测(3)
http://www.100md.com 2013年6月15日 李乃静 李伟 李岩
第1页

    参见附件。

     [7] Beckonert O,Keun HC,Ebbels TM,et al. Metabolic profiling, metabolomic and metabolomic procedures for NMR spectroscopy of urin,plasma,serum and tissue extracts [J]. Nat Protoc,2007,2:2692-2703.

    [8] Shi YQ,Huang TW,Chen LM,et al. Ginsenoside-Rg1 attenuates amyloid-beta content regulates PKA/CREB activity and improves cognitive performance in SAMP8 mice [J]. J Alzheimers Dis,2010,19:977-989.

    [9] Xie X,Wang HT,Li GL,et al. Ginsenoside Rb1 protects PC12 ells against β-amyloid- induced cell injury [J]. Mol Med Report,2010,3:635-639.

    [10] Scherzer-Attali R,Farfara D,Cooper I,et al. Naphthoquinone- tyrptophan reduces neurotoxic Aβ 56 levels and improves cognition in Alzheimer's diseaseanimal model [J]. Neurobiol Dis,2012,46:663-672.

    [11] Scheizer-Attali R,Shaltiel-Karyo R,Adalist YH,et al. Generic inhibition of amyloidogenic proteins by two naphthoquinone- tryptophan hybrid molecules [J]. Proteins,2012,80:1962-1973.

    (收稿日期:2013-01-24 本文编辑:程 铭)

您现在查看是摘要介绍页,详见PDF附件